aap Implantate AG

Director's Dealing • Dec 18, 2024

News Details

Directors’ Dealings | 17 December 2024 12:31

aap Implantate AG: Merval AG, Purchase of shares through the exercise of conversion rights

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

17.12.2024 / 12:31 CET/CEST

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Name and legal form:	Merval AG

2. Reason for the notification

a) Position / status

Person closely associated with:
Title:	Dr. med.
First name:	Nathalie
Last name(s):	Krebs
Position:	Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

aap Implantate AG

b) LEI

39120001TRQTQ01LPP57

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Financial instrument linked to a share or a debt instrument
ISIN:	DE000A351ZH9

b) Nature of the transaction

Purchase of shares through the exercise of conversion rights

c) Price(s) and volume(s)

Price(s)	Volume(s)
1.03 EUR	149,999.93 EUR

d) Aggregated information

Price	Aggregated volume
1.03 EUR	149,999.93 EUR

e) Date of the transaction

2024-06-11; UTC+1

f) Place of the transaction

Outside a trading venue

---

17.12.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---

Language:	English
Company:	aap Implantate AG
	Lorenzweg 5
	12099 Berlin
	Germany
Internet:	www.aap.de

End of News	EQS News Service